Overview

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose: To investigate the diagnostic accuracy of 18F-FLT PET for the suspicious lesions on mammograms and ultrasound.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Alovudine
Criteria
Inclusion Criteria:

1. Women aged between 20 to 80 years

2. women who have localized findings on mammography and / or ultrasound and will receive
biopsy.

3. The lesions on the conventional imaging measure >=1cm

4. WBC count >=3000/L, or platelet>=75,000/L

5. Liver function, AST or ALT < 78 U/L

6. Renal function, Creatinine < 2.0 mg/dl.The laboratory examinations should be performed
within 4months before our study.

Exclusion Criteria:

1. Pregnant women or who are planning to be pregnant.

2. Known cancers in other organs.

3. Women who are not able to cooperate with the PET/CT examination.